These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 362235)

  • 1. Methods of modifying the immune response.
    Jones JV
    Neurology; 1978 Sep; 28(9 Pt 2):115-8. PubMed ID: 362235
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral antibodies in multiple sclerosis.
    Norrby E
    Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis: an immunologic reassessment.
    Paterson PY
    J Chronic Dis; 1973 Mar; 26(3):119-26. PubMed ID: 4348606
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immune studies in multiple sclerosis.
    Bar-Or A
    Adv Neurol; 2006; 98():91-109. PubMed ID: 16400829
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Immunological tolerance.
    Lancet; 1975 Mar; 1(7906):555-6. PubMed ID: 47021
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective immunosuppression using antigens and antibodies as pharmacologic agents.
    Siskind GW
    Fed Proc; 1974 Aug; 33(8):1886-8. PubMed ID: 4135738
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of thymus epithelial tissue in the formation of natural immune tolerance].
    Beletskaia LV; Gnezditskaia EV
    Usp Sovrem Biol; 1975; 79(1):128-37. PubMed ID: 1092082
    [No Abstract]   [Full Text] [Related]  

  • 8. The immune response and cancer. A guide.
    Gilbert HA; Kagan AR
    Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis: evidence for immunopathogenesis.
    Lisak RP
    Neurology; 1980 Jul; 30(7 Pt 2):99-105. PubMed ID: 6993994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intrathecal immune response in multiple sclerosis: a different concept of 'specificity'.
    Lauer K
    Med Hypotheses; 1990 Apr; 31(4):245-51. PubMed ID: 2192234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens.
    Rocklin RE; Sheremata WA; Feldman RG; Kies MW; David JR
    N Engl J Med; 1971 Apr; 284(15):803-8. PubMed ID: 4323673
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immune functions in multiple sclerosis.
    O'Gorman M; Oger J
    Pathol Immunopathol Res; 1987; 6(4):241-72. PubMed ID: 3329340
    [No Abstract]   [Full Text] [Related]  

  • 13. Innate Lymphoid Cells in the Central Nervous System.
    Wang S; van de Pavert SA
    Front Immunol; 2022; 13():837250. PubMed ID: 35185929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The ontogeny of immunity].
    García Tamayo F
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):550-62. PubMed ID: 6763539
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
    Steinman L; Martin R; Bernard C; Conlon P; Oksenberg JR
    Annu Rev Neurosci; 2002; 25():491-505. PubMed ID: 12052918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.
    Merrill JE; Graves MC; Mulder DG
    West J Med; 1992 Jun; 156(6):639-46. PubMed ID: 1319627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune reactions in the central nervous system].
    Iivanainen M; Taskinen E
    Duodecim; 1986; 102(5):281-9. PubMed ID: 3486107
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH; Golub SH
    Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune tolerance to myelin proteins.
    Seamons A; Perchellet A; Goverman J
    Immunol Res; 2003; 28(3):201-21. PubMed ID: 14713715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.